Navigation Links
Global Hormone Replacement Therapy (HRT) Industry
Date:11/7/2011

NEW YORK, Nov. 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Hormone Replacement Therapy (HRT) Industry

http://www.reportlinker.com/p0681889/Global-Hormone-Replacement-Therapy-HRT-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biologica

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 42 companies including many key and niche players such as Bayer HealthCare Pharmaceuticals, Inc., Besins Healthcare SA, Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Mylan Canada, Novartis AG, Novo Nordisk A/S, Orion Corporation, Pfizer, Inc., Wyeth Pharmaceuticals, Inc., Rottapharm SpA, Teva Pharmaceutical Industries Ltd., Theramex, Warner Chilcott, and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definition and Scope of Study 3

2. INDUSTRY OVERVIEW 5

WHI Study- A Major Blow to the HRT Market 5

An Overview 6

Milestones and Downf
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
2. Glenmark Wins Two Prestigious Global Recognitions at SCRIP Awards 2011
3. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
4. Global Top 10 Medical Devices Market (2010 - 2015)
5. Global Trend in Diabetes Could Exact Catastrophic Toll on Emerging Global Healthcare Systems
6. The Global Market for Diabetes Drugs and Devices is Booming: Expected to Attain a Market Size of USD 114.3 Billion by 2016
7. Sanofi Tops Pfizer as Number One for Global Pharma Sales
8. Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
9. Philips Enters North American Mammography Market, Underscoring its Global Commitment to Womens Health Care
10. Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
11. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... -- Cepheid (Nasdaq: CPHD ) today reported revenues ... representing growth of 15% from $100.1 million for the ... quarter of 2014 was $(7.2) million, or $(0.10) per ... or $(0.02) per share, in the third quarter of ... of debt discount and transaction costs, and amortization of ...
(Date:10/16/2014)... Oct. 16, 2014   DaVita HealthCare Partners ... of the nation,s largest and most innovative health ... ranked DaVita HealthCare Partners 37 th overall ... article in Harvard Business Review (HBR). ... which evaluates companies based on reputation strength, considers ...
(Date:10/16/2014)... 16, 2014 Eight finalists, all representing outstanding ... present their proposals for a chance to compete for ... Sheikh Zayed Institute Second Annual Pediatric Surgical Innovation Symposium ... on Friday, Oct. 24, 2014. Selected from ... the US and internationally, the finalists are: ...
Breaking Medicine Technology:Cepheid Reports 2014 Third Quarter Results 2Cepheid Reports 2014 Third Quarter Results 3Cepheid Reports 2014 Third Quarter Results 4Cepheid Reports 2014 Third Quarter Results 5Cepheid Reports 2014 Third Quarter Results 6Cepheid Reports 2014 Third Quarter Results 7Cepheid Reports 2014 Third Quarter Results 8Cepheid Reports 2014 Third Quarter Results 9Cepheid Reports 2014 Third Quarter Results 10Cepheid Reports 2014 Third Quarter Results 11Cepheid Reports 2014 Third Quarter Results 12Cepheid Reports 2014 Third Quarter Results 13Cepheid Reports 2014 Third Quarter Results 14Cepheid Reports 2014 Third Quarter Results 15Cepheid Reports 2014 Third Quarter Results 16Cepheid Reports 2014 Third Quarter Results 17Harvard Business Review Recognizes DaVita HealthCare Partners 2Harvard Business Review Recognizes DaVita HealthCare Partners 3Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4
... 2007 /PRNewswire/ -- DNA Therapeutics,S.A. an emerging pharmaceutical ... elucidation of a new mechanism,of action and the ... molecule Dbait. It will be,presented at the forecoming ... abstract is now available online.,The presentation itself will ...
... Potent Synergy, Activity and Patient Tolerance Support ... Spain, April 12, 2007 /PRNewswire/ -- Intarcia,Therapeutics, ... final results from a Phase 2 study ... treatment-naive patients,with genotype 1 chronic hepatitis C. ...
Cached Medicine Technology:DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 2DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4
(Date:10/20/2014)... Succeed is proud to announce that they ranked in the ... Every Body Walk! campaign by Kaiser Permanente. Every ... to be more active outside of the workplace. This ... end of September, was a friendly competition between organizations across ... companies gave their staff pedometers and each day, for the ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
(Date:10/19/2014)... UNITED NATIONS, New York (PRWEB) October 19, 2014 ... the United Nations Population Fund, welcomes news of a ... release of the more than 200 girls who were ... Girls. "These girls have languished in captivity long enough, ... their families, schools and communities," stated Dr. Osotimehin. , ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many kinds ... designs of 2014 mother of the bride dresses ... offered with big discounts, up to 70% off. All ... enjoy this special offer. , Owing to the ... one of the leading brands in the global market. ...
Breaking Medicine News(10 mins):Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
... $247 billion a year, experts say , , FRIDAY, Feb. ... in young Americans cost the nation about $247 billion ... government to make preventing these disorders and promoting mental ... such as depression, anxiety, conduct disorders and substance abuse ...
... PARAMUS, N.J., Feb. 13 Smart Balance, Inc. (Nasdaq: ... Executive Officer of Smart Balance, Inc., will make a presentation ... in Dana Point, CA, at 2 p.m. EST on Tuesday, ... in length. Only conference attendees will be able to ...
... clinical research community have already pledged support WASHINGTON, ... National Standards Institute (ANSI), coordinator of the ... to facilitate the use of electronic health information ... seeks the active engagement and financial support of ...
... SALT LAKE CITY, Feb. 13 Dynatronics Corporation (Nasdaq: ... quarter and six months ended December 31, 2008. Operating results ... December 31, 2007. Pre-tax profit for the quarter ended December ... of $521,656 for the second quarter of the prior fiscal ...
... Micromet, Inc. (Nasdaq: MITI ), today announced that its ... Orange County Growth Stock Conference at the Ritz-Carlton Laguna Niguel on Wednesday, ... Orange County Growth Stock Conference, Date: Wednesday, ... Time, Place: The Ritz-Carlton Laguna Niguel, ...
... FRANCISCO, Feb. 13, 2009 New techniques used to ... the wild are yielding surprising results about hormones and ... social structure of a broader range of mammals. , ... findings at the AAAS meeting that examine social stress ...
Cached Medicine News:Health News:Report Urges Broader Effort to Stem Emotional Disorders in Youth 2Health News:ANSI Seeks Funding to Ensure that Electronic Health Records Will Support Clinical Research Activities 2Health News:ANSI Seeks Funding to Ensure that Electronic Health Records Will Support Clinical Research Activities 3Health News:ANSI Seeks Funding to Ensure that Electronic Health Records Will Support Clinical Research Activities 4Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 2Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 4Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 2Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 3Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 4Health News:Findings raise new questions about evolution of hormones in mammals 2
... This functional brace is designed for the ... and fibula. The preformed design provides post ... removal of internal or external fixation. The ... and below the fracture site, increasing vascularity ...
... Brace features a multi-axial hinge that duplicates ... altering kinematics. The infinite degree of adjustment ... and extension control of the knee. , ... tibia in correct anatomical alignment. The precision ...
... is a revolutionary cast replacement system for ... leg and foot. , ,A self-adjusting ... and in conjunction with a rigid lattice ... time of fracture or rupture healing can ...
... the constant demands of mobilizing patients quickly. ... necessary to fit bilateral KAFO's.,The complete kit ... knee joints , 4 Copolymer thigh support ... bands , Ortho-wick™ Padding for thigh , ...
Medicine Products: